Literature DB >> 20582233

Mechanisms of self-nonself discrimination and possible clinical relevance.

Carolin Daniel1, Jens Nolting, Harald von Boehmer.   

Abstract

This review discusses different mechanisms that result in immunological tolerance, such as intrathymic deletion of immature T cells, intrathymic and extrathymic generation of regulatory T cells, effector mechanisms of regulatory T cells as well as molecular pathways involved in extrathymic generation of regulatory T cells in vivo and in vitro. These molecular mechanisms should enable investigators to develop clinical protocols aiming at the specific prevention of unwanted immune responses, thereby replacing indiscriminate immunosuppression that often has fatal consequences.

Entities:  

Keywords:  Foxp3; TGF-β; conversion; recessive and dominant tolerance; regulatory T cell; self–nonself discrimination; suppression

Mesh:

Substances:

Year:  2009        PMID: 20582233      PMCID: PMC2891266          DOI: 10.2217/imt.09.29

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  119 in total

Review 1.  Die and let live: eliminating dangerous lymphocytes.

Authors:  A K Abbas
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

2.  The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells.

Authors:  L Bruno; H J Fehling; H von Boehmer
Journal:  Immunity       Date:  1996-10       Impact factor: 31.745

3.  A role for CD95 ligand in preventing graft rejection.

Authors:  D Bellgrau; D Gold; H Selawry; J Moore; A Franzusoff; R C Duke
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

4.  Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).

Authors:  C Zimmermann; M Rawiel; C Blaser; M Kaufmann; H Pircher
Journal:  Eur J Immunol       Date:  1996-12       Impact factor: 5.532

5.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

6.  Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein.

Authors:  S J Antonia; T Geiger; J Miller; R A Flavell
Journal:  Int Immunol       Date:  1995-05       Impact factor: 4.823

7.  Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule.

Authors:  H Jiang; R Ware; A Stall; L Flaherty; L Chess; B Pernis
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

8.  Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection.

Authors:  S Martin; M J Bevan
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

9.  T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus.

Authors:  C Jolicoeur; D Hanahan; K M Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.

Authors:  G G Singer; A K Abbas
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

View more
  4 in total

1.  PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors.

Authors:  Matthias Merkenschlager; Harald von Boehmer
Journal:  J Exp Med       Date:  2010-07-05       Impact factor: 14.307

2.  A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma.

Authors:  Cristian Capasso; Aniket Magarkar; Victor Cervera-Carrascon; Manlio Fusciello; Sara Feola; Martin Muller; Mariangela Garofalo; Lukasz Kuryk; Siri Tähtinen; Lucio Pastore; Alex Bunker; Vincenzo Cerullo
Journal:  Oncoimmunology       Date:  2017-05-11       Impact factor: 8.110

3.  The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.

Authors:  Edward Banham-Hall; Menna R Clatworthy; Klaus Okkenhaug
Journal:  Open Rheumatol J       Date:  2012-09-07

4.  Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.

Authors:  Xiao Zhang; Erich Sabio; Chirag Krishna; Xiaoxiao Ma; Jingming Wang; Hui Jiang; Jonathan J Havel; Timothy A Chan
Journal:  Mol Cancer Res       Date:  2021-03-05       Impact factor: 5.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.